New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
08:44 EDTPTXPernix Therapeutics upgraded at Needham
As previously reported, Needham upgraded Pernix to Strong Buy from Buy. The analyst said Pernix's purchase of Treximet is a "game changer" and should increase short-term profitability and provides an anchor in the CNS market. Price target raised to $10 from $9.
News For PTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
12:37 EDTPTXOn The Fly: Top stock stories at midday
Subscribe for More Information
09:18 EDTPTXOn The Fly: Pre-market Movers
Subscribe for More Information
April 15, 2015
18:56 EDTPTXOn The Fly: After Hours Movers
Subscribe for More Information
16:09 EDTPTXPernix Therapeutics says results impacted by lower Treximet prescription volume
Subscribe for More Information
16:05 EDTPTXPernix Therapeutics sees FY15 revenue$220M-$240M, consensus $237.47M
Subscribe for More Information
16:04 EDTPTXPernix Therapeutics sees Q1 revenue $32M-$35M, consensus $49.52M
Subscribe for More Information
16:02 EDTPTXPernix announces private placement of $120M convertible senior notes due 2021
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use